Literature DB >> 20963538

Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.

Ronald G Schwartz.   

Abstract

Mesh:

Year:  2010        PMID: 20963538     DOI: 10.1007/s12350-010-9295-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  52 in total

1.  Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy.

Authors:  I Yokoyama; S Momomura; T Ohtake; K Yonekura; W Yang; N Kobayakawa; T Aoyagi; S Sugiura; N Yamada; K Ohtomo; Y Sasaki; M Omata; Y Yazaki
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

2.  Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up.

Authors:  Stefano Sdringola; Catalin Loghin; Fernando Boccalandro; K Lance Gould
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

3.  High prevalence of myocardial perfusion abnormalities on positron emission tomography in asymptomatic persons with a parent or sibling with coronary artery disease.

Authors:  S Sdringola; D Patel; K L Gould
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

4.  Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.

Authors:  D Baller; G Notohamiprodjo; U Gleichmann; J Holzinger; R Weise; J Lehmann
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

5.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

6.  Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors.

Authors:  Thomas H Schindler; Egbert U Nitzsche; Manfred Olschewski; Nobuhisa Magosaki; Michael Mix; John O Prior; Alvaro D Facta; Ulrich Solzbach; Hanjoerg Just; Heinrich R Schelbert
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

7.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

8.  Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

Authors:  M Guethlin; A M Kasel; K Coppenrath; S Ziegler; W Delius; M Schwaiger
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

Review 10.  Anatomy and physiology of coronary blood flow.

Authors:  Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

View more
  1 in total

Review 1.  Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?

Authors:  Sven Hermann; Andrea Starsichova; Bianca Waschkau; Michael Kuhlmann; Christian Wenning; Otmar Schober; Michael Schäfers
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.